Portnoy Law Firm Announces Class Action on Behalf of Regeneron Pharmaceuticals, Inc. Investors
LOS ANGELES, July 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regeneron Pharmaceuticals, Inc., (“Regeneron” or the "Company") (NASDAQ: REGN) investors of a class action on behalf of investors that bought securities between August 1, 2025 and May 15, 2026, inclusive (the “Class Period”). Regeneron investor…
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


